Etanercept for the treatment of rheumatoid arthritis.
BACKGROUND: Etanercept is a soluble tumour necrosis factor alpha-receptor disease-modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). OBJECTIVES: The purpose of this review was to update the previous Cochrane systematic review published in 2003 assessing the benefi...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2013
|